Moderna : 2024 ESCMID (mRNA-1010) - MarketScreener
Safety and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine in Healthy Adults Mieke Soens, Raffael...
Source: marketscreener.com
Stay updated with breaking news from Active Controlled Study Evaluating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Safety and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine in Healthy Adults Mieke Soens, Raffael...
22.12.2021 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials in all ongoing clinical studies for HIV treatment and HIV ... Seite 1